Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study (NCT07094529)
The Feasibility of Personalized Hypoglycemia Outpatient Treatment for People Living With Type 2 Diabetes Mellitus
🩺 Plain-English Summary (8th-Grade Level)
This study will offer two study interventions designed to bring on a mild low blood sugar (capillary blood glucose result 3.0 to 3.8 mmol/L), in order to study the effectiveness of each study participant's personal choice of treatment and first recheck time. The two study interventions that the participant can choose to complete (one or both interventions). Based on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities, and choose one of 4 capillary blood glucose recheck times.
Who can join: Review the eligibility criteria below.
Location: The Ottawa Hospital — Ottawa, Ontario
Age range: 18 Years
🧪 Interventions in This Study
- Recumbent Exercise Bike to induce mild hypoglycemia (BEHAVIORAL)
- Delaying food to induce mild hypoglycemia, (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- The Ottawa Hospital — Ottawa, Ontario
📞 Contact the Study Coordinator
Phone: (613) 738-8333
Email: csun@toh.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes (T2DM)
- Optimizing Lifestyles Through Increased Vegetable-rich Eating Pilot Study — Columbia, South Carolina
- Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists — Brooklyn, New York
- Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes — Milwaukee, Wisconsin
- Using Virtual Reality to Improve Medical Training — Athens, Ohio
Explore by condition: All Type 2 Diabetes (T2DM) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.